BEHÇET’S DISEASE, A CLINIC CASE PRESENTATION
DOI:
https://doi.org/10.15332/us.v7i1.1200Keywords:
Sores, Multiple ulcers, Stomatology, Artralgy, InterdisciplinaryAbstract
The Behçet’s disease is an entity with diverse manifestations, inside which are observed oral and genital sores primarily, arthritic manifestations, ocular commitments as uveitis, vasculitis and occasionally affection of the system nervous and big glasses. In relation to the causes that can originate it diverse theories have been studied, taking in the last years much force those of immunologic origin, especially for the existence of HLA - B51 and a lack of immunologic control, to these theories they continue others that make responsible infectious agents, the damage endotelial, and others. Lately, this concluding that all these entities contribute in their etiopatogenia acting in diverse moments, where some infectious agents can shoot an answer on the part of the mononuclear’s and endothelia’s cells, those which in a susceptible individual for the presence of HLA - B51, would produce the generation of an inflammatory answer finally, concluding in a vasculitis. Such a complex syndrome, the proposed treatments have been multiple, agents inmunosupresores imply, colchicina, steroids talidomida, depending their handling of the systemic existent commitment. The purpose of this paper is to expose the characteristics of the pathology in different systems as well as the conduction of a patient with this disease, making emphasis in the difficulties for the I diagnose, the necessity of a work in team and the importance of the dentist in this team.Downloads
References
Ghate JV, Jorizzo JL. Behcet’s disease and complex aphthosis. J Am Acad Dermatol 1999; 40: 1 - 18.
Yazici H, Yurdakul S, Hamuyudan V. Behçet´s disease. Curr Opin Rheumatol 2001; 13: 18 - 22.
Bang D. clinical spectrum of Behçet´s disease. J Dermatol 2001; 28: 610 - 613.
Jacyk WK. Behcet’s disease in South African blacks: report of five cases. J Am Acad Dermatol 1994; 30: 869 – 873.
Goker B, Goker H. current therapy for Behçet disease. Am J Ther 2002; 9: 465 – 470.
Monder MA. The multiple faces of Behçet´s disease and its aetiological factors. J Eur Acad Dermatol Venereol 2001; 15: 126 - 136.
Dundar SV, Gencalp U, Simsek H. Familial cases of Behcet’s disease. Br J Dermatol. 1985; 113:319 -21.
Gul A. Behçet´s disease: an update on the pathogenesis. Clin Exp Rheumatol. 2001; 19: 6 -12.
Dinarello CA. Interleukin -1 and the pathogenesis of the acute phase response. N Engl J Med 1984; 311: 1413 - 1418.
Valesini G, Pivetti - Pezzi P, Mastrandrea F, Moncada A, Cuomo M, Natali PG. Evaluation of T cell subsets in Behcet’s syndrome using anti -T cell monoclonal antibodies. Clin Exp Immunol 1985; 60: 55 – 60.
Sancak B, Onder M, Oztas MO, Bukan N, Gurer MA. Nitric oxide levels in Behcet´s disease. J Eur Acad Dermatol Venereol 2003; 17: 7 - 9.
Koçak M, Erbast A, Ozturk G, Eksioglu M. Behçet´s disease and nitric oxide production. Int J Dermatol 2003; 42: 244 – 248
Nussenblat R, Whitcup S, Palestine A. Behçet disease. En: Uveitis Fundamentals and Clinical Practice. 2nd. Ed. Ed Mosby; 1996. p. 334 – 353.
Cappele O, Nicolas J, Bottet P, Bensadoun H. Urological manifestations of Behçet´s disease. Prog Urol 2003; 13: 329 - 331.
Jorizzo JL. Behcet’s disease: an update based on the 1985 international conference in London. Arch Dermatol 1986; 122: 556 - 558.
Balanova M, Calamia K, Perniciario C, O´ Duffy J.D. A study of the cutaneous manifestations of Behçet´s disease in patients of the United States. J Am Acad Dermatol 1999; 41: 540 - 545.
Dogan B, Taskapan O, Harmanyeri Y. prevalence or pathergy test positivity in Behçet´s disease in Turkey. J Eur Acad Dermatol Venereol 2003; 17: 228 - 229.
Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behcet’s disease: an international collaborative study. Br J Ophthalmol 2007; 91: 1579 – 1582.
Matsuo T, Itami M, Nakagawa H, Nagayama M. The incidence and pathology of conjuntival ulceration in Behçet’s Syndrome. Br J Ophthalmol 2002; 86: 140 - 143.
Tohme A, Haddad F, Ghayad E. Neurologic manifestations in Behcet’s disease. 16 cases in a cohort of 110 patients. Ann Internal Med 1997; 148: 118 – 124.
Ozturk MA, Ertenli I, Kiraz S, C Haznedaroglu I, Celik I, Kirazli S, Calguneri M. Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet´s disease. Rheumatol Int 2004; 24: 98 - 102.
Bowles CA, Nelson AM, Hammill SC, O’Duffy JD. Cardiac involvement in Behcet’s disease. Arthritis Rheum 1985; 28: 345 - 348.
Hamza M. Large artery involvement in Behcet’s disease. J Rheumatol 1987; 14: 554 - 559.
Skare TL, Silva TQ, Pastro PC. Uveitis and spondyloarthritis: prevalence and relationship with joint disease. Arq Bras Oftalmol 2007; 70: 827 - 830.
Howland W, Golitz L, Weston W, Huff J. Erythema multiforme: clinical, histopathologic, and immunologic study. J Am Acad Dermatol 1984; 10: 438 – 446.
Marini M, Parra L, Casas J. Herpetiform pemphigus: case report and literature review. Arch argent Dermatol 2004; 54: 103 - 108.
Haubrich WS. Behçet of Behçet’s síndrome. Gastroenterology. 2008;134:38
Kobayashi TK, Kaneko C, Sugishima S, Kusukawa J, Kameyama T. Scrape cytology of oral pemphigus. Report of a case with immunocytochemistry and light, scanning electron and transmission electron microscopy. Acta Cytol 1999; 43: 289 - 294.
Rushton R, Chir C. The treatment of ulcerative mouth lesions with Orabase. Br J Dermatol 1962; 74: 462 – 463.
